Eloxx Pharmaceuticals, Inc.: Form 8-K, filed Mar 9, 2023
Filed with the SEC on Mar 9, 2023 and accepted by EDGAR at Mar 9, 2023, 21:12 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 2.03 New direct financial obligation
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000950170-23-007032. Last ingested by Listed: Oct 24, 2026, 15:04 ET. Listed shows no prices and gives no investment advice.